Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heideman

Showing results (121-130 of 272) with videos related to

Pageof 28
Sort By:
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|May 30, 2009
A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutationsD Kramer, F B Thunnissen, M I Gallegos-Ruiz, et al.
Journal of Medical Virology|July 16, 2016
Cutaneous human papillomavirus genotypes in different kinds of skin lesions in ArgentinaRita Mariel Correa, Sara Vladimirsky, Daniëlle A M Heideman, et al.
Sexually Transmitted Diseases|July 15, 2016
Prevalence of Neovaginal High-Risk Human Papillomavirus Among Transgender Women in The NetherlandsWouter B van der Sluis, Marlon E Buncamper, Mark-Bram Bouman, et al.
International Journal of Cancer|April 18, 2018
Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-upLise M A De Strooper, Johannes Berkhof, Renske D M Steenbergen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 5, 2013
Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudyMaaike G Dijkstra, Dirk van Niekerk, Dorien C Rijkaart, et al.
Viruses|May 28, 2022
Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer ScreeningDaniëlle A M Heideman, Anja Oštrbenk Valenčak, Saskia Doorn, et al.
Journal of Clinical Microbiology|August 30, 2013
The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screeningD A M Heideman, A T Hesselink, F J van Kemenade, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 26, 2018
The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath mediumJesper Bonde, Ditte Møller Ejegod, Kate Cuschieri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 9, 2024
Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflowD A M Heideman, J Berkhof, L Verhoef, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 5, 2010
High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR productsD T Geraets, D A M Heideman, M N C de Koning, et al.
Pageof 28

Showing results (121-130 of 272) with videos related to

Sort By:
Pageof 28
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|May 30, 2009
A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutationsD Kramer, F B Thunnissen, M I Gallegos-Ruiz, et al.
Journal of Medical Virology|July 16, 2016
Cutaneous human papillomavirus genotypes in different kinds of skin lesions in ArgentinaRita Mariel Correa, Sara Vladimirsky, Daniëlle A M Heideman, et al.
Sexually Transmitted Diseases|July 15, 2016
Prevalence of Neovaginal High-Risk Human Papillomavirus Among Transgender Women in The NetherlandsWouter B van der Sluis, Marlon E Buncamper, Mark-Bram Bouman, et al.
International Journal of Cancer|April 18, 2018
Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-upLise M A De Strooper, Johannes Berkhof, Renske D M Steenbergen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 5, 2013
Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudyMaaike G Dijkstra, Dirk van Niekerk, Dorien C Rijkaart, et al.
Viruses|May 28, 2022
Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer ScreeningDaniëlle A M Heideman, Anja Oštrbenk Valenčak, Saskia Doorn, et al.
Journal of Clinical Microbiology|August 30, 2013
The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screeningD A M Heideman, A T Hesselink, F J van Kemenade, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 26, 2018
The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath mediumJesper Bonde, Ditte Møller Ejegod, Kate Cuschieri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 9, 2024
Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflowD A M Heideman, J Berkhof, L Verhoef, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 5, 2010
High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR productsD T Geraets, D A M Heideman, M N C de Koning, et al.
Pageof 28